A Radical New Union 
For Healthcare

Tom Manning is the Chairman of Ascertain, the AI JV between Aegis Ventures and Northwell Health. From founding McKinsey’s healthcare practice, to serving as CEO of one of the first U.S. telemedicine companies, and most recently, as Chairman and CEO of Dun & Bradstreet – Tom’s appointment is the culmination of decades at the intersection of AI, venture creation, and healthcare technology.

John Beadle is Managing Partner of Aegis Ventures. John co-founded the venture studio alongside Aegis's Chairman Bill Schoenfeld and has led the studio's day-to-day executive functions since inception. John also leads Special Situations at APL Group, a global private investment firm, and Aegis's sister company. Previously, John served in roles at BofA Merrill Lynch and John Laing Group.

As President, Strategic Initiatives and Chief Operating Officer, Mark Solazzo provides leadership and oversight to all operations for Northwell Health, including its hospitals, long-term care facilities, the nation’s sixth largest physician group practice, and emerging healthcare-related businesses. He oversees a workforce of more than 78,000 employees throughout Northwell, the largest private employer in New York State.

Richard Mulry is the President and CEO of Northwell Holdings, Northwell Health’s business arm dedicated to investment in innovation and commercialization of services through product launch and novel joint ventures. Previously, he held senior leadership roles building physician enterprises within academic medical centers, as well as a senior manager role in the healthcare management practice at PricewaterhouseCoopers.

Dr. Zachary Tan MD is a Venture Creation Partner at Aegis Ventures and Ascertain, the AI JV between Aegis and Northwell Health. He is a physician, researcher, and entrepreneur and helps lead the ideation, venture creation, and investment of the studio’s new ventures. In addition to his clinical practice, Dr. Tan has published over 20 peer-reviewed publications and textbook chapters including in healthcare AI, and was Chief Strategy Officer of CancerAid, a virtual care company that has partnered with dozens of leading insurer and employer customers.

Dr. Trung Nghia Ton MD is a Venture Creation Partner at Aegis Ventures and Ascertain, the AI JV between Aegis and Northwell Health. He is a physician, public health practitioner, and health strategy and innovation expert and helps lead the ideation, venture creation, and investment of the studio’s new ventures. In addition to his clinical practice, Dr. Ton has previously led health tech startups, was a consultant for McKinsey & Company and has worked as an advisor to public and private healthcare leaders across digital transformation, innovation and health technology.

Marek Sirendi PhD leads AI/ML model development and the 0-to-1 scaling of Ascertain’s AI ventures. He is an experienced healthcare entrepreneur and CTO, MIT Innovators Under 35 honoree, and a researcher with a passion for the transformative power of health technology. As a former CERN physicist, he contributed to the discovery of the Higgs boson and carried out the world's most precise measurement of lepton universality.

Marc Paradis oversees and coordinates Northwell Health's internal and external investments in Data, Algorithms, Machine Learning, Artificial Intelligence and Data Science. He has over 20 years of experience in data, data warehousing, business intelligence, machine learning, artificial intelligence and data science across payer, provider, pharma and revenue cycle healthcare verticals.

Dr. Melynda Barnes, MD, is the CMO of Ro, a $5B company delivering virtual healthcare services. Before Ro, she was an Assistant Professor of Surgery-Otolaryngology at Yale School of Medicine and served on Yale Medical Group’s Board of Directors. She has been recognized as a 40 Under 40 Leader in Health.

Dr. Mark Michalski, MD, is Amazon’s Global Head of Healthcare Artificial Intelligence and Machine Learning Business Development group. He was a founding Executive Director of the Mass Gen Brigham Center for Clinical Data Science. Prior, he held leadership roles at Butterfly Network and Hyperfine Research.